# Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/effect-of-fremanezumab-compared-with-placebo-for-prevention-of-episodic-migraine/

## Facts

| Field | Value |
| --- | --- |
| Author Names | David W. Dodick,Stephen D. Silberstein,Marcelo E. Bigal,Paul Yeung,Peter J. Goadsby,Tricia Blankenbiller,Melissa Grozinski‐Wolff,Ronghua Yang,Yuju Ma,Ernesto Aycardi |
| Citations | 578 |
| DOI | 10.1001/jama.2018.4853 |
| Fields | Medicine,Neuroscience |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://jamanetwork.com/journals/jama/articlepdf/2681193/jama_dodick_2018_oi_180039.pdf |
| OpenAlex ID | https://openalex.org/W2803715733 |
| PMID | 29800211 |
| Type | article |
| Year | 2018 |

## Paper authors

- [David W. Dodick](https://scholariq.org/researchers/david-w-dodick/)

## Paper journal

- [JAMA](https://scholariq.org/journals/jama/)

## Paper primary topic

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)

## Paper topics

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Neurological Disorders and Treatments](https://scholariq.org/topics/neurological-disorders-and-treatments-2/)
- [Neurological Complications and Syndromes](https://scholariq.org/topics/neurological-complications-and-syndromes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.